CS Diagnostics Corp.
CS Diagnostics Corp. engages in designing, manufacturing, and selling of wellness and medical products in Germany and internationally. The company offers MEDUSA, proprietary surface disinfectant product; and CS-Protect Hydrogel, a tissue spacer gel for use in radiation therapy. The company was formerly known as FlashZero Corp. and changed its name to CS Diagnostics Corp. in August 2023. The compa… Read more
CS Diagnostics Corp. (CSDX) - Net Assets
Latest net assets as of September 2025: $499.43 Million USD
Based on the latest financial reports, CS Diagnostics Corp. (CSDX) has net assets worth $499.43 Million USD as of September 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($499.43 Million) and total liabilities ($1.61K). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $499.43 Million |
| % of Total Assets | 100.0% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | N/A |
CS Diagnostics Corp. - Net Assets Trend (None–None)
This chart illustrates how CS Diagnostics Corp.'s net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for CS Diagnostics Corp. (None–None)
The table below shows the annual net assets of CS Diagnostics Corp. from None to None.
| Year | Net Assets | Change |
|---|---|---|
| No yearly data available. | ||
Equity Component Analysis
This analysis shows how different components contribute to CS Diagnostics Corp.'s total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- No equity composition insights available.
CS Diagnostics Corp. Competitors by Market Cap
The table below lists competitors of CS Diagnostics Corp. ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Tower Resources Ltd
PINK:TWRFF
|
$10.55 Million |
|
Thunder Mountain Gold Inc
OTCQB:THMG
|
$10.55 Million |
|
Future Enterprises Limited
NSE:FELDVR
|
$10.55 Million |
|
Hankukpackage Co. Ltd
KQ:037230
|
$10.56 Million |
|
Table Trac Inc
OTCQX:TBTC
|
$10.54 Million |
|
Ostim Endustriyel Yatirimlar ve Isletme AS
IS:OSTIM
|
$10.54 Million |
|
PPX Mining Corp
PINK:SNNGF
|
$10.53 Million |
|
Tong-Hwa Synthetic Fiber Co Ltd
TW:1418
|
$10.53 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in CS Diagnostics Corp.'s equity between the two most recent reporting periods.
Insufficient data available to analyze equity growth attribution.
Book Value vs Market Value Analysis
This analysis compares CS Diagnostics Corp.'s book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Insufficient data available to analyze book value vs market value.
Capital Efficiency Dashboard
This dashboard shows how efficiently CS Diagnostics Corp. utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Insufficient data available to analyze capital efficiency metrics.
Industry Comparison
This section compares CS Diagnostics Corp.'s net assets metrics with peer companies in the Medical Devices industry.
Industry Context
- Industry: Medical Devices
- Average net assets among peers: $694,749,556
- Average return on equity (ROE) among peers: -25.46%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| CS Diagnostics Corp. (CSDX) | $499.43 Million | N/A | 0.00x | $10.54 Million |
| Advanced Biomedical Technologies Inc (ABMT) | $-4.46 Million | 0.00% | 0.00x | $14.18K |
| Abbott Laboratories (ABT) | $4.82 Billion | 39.04% | 1.31x | $191.37 Billion |
| Acarix AB (publ) (ACIXF) | $1.93 Million | -127.02% | 0.21x | $26.42 Million |
| Adagio Medical Holdings, Inc Common Stock (ADGM) | $-72.62 Million | 0.00% | 0.00x | $4.05 Million |
| Adm Tronics Unltd (ADMT) | $-12.69K | 0.00% | 0.00x | $3.17 Million |
| Aethlon Medical Inc (AEMD) | $-3.07 Million | 0.00% | 0.00x | $2.79 Million |
| Acutus Medical Inc (AFIB) | $126.58 Million | -80.56% | 0.52x | $732.88K |
| Adapthealth Corp (AHCO) | $2.07 Billion | 7.56% | 1.54x | $914.25 Million |
| Allied Healthcare Products Inc. (AHPIQ) | $8.88 Million | -33.95% | 1.22x | $726.24 |
| 20/20 Biolabs, Inc. Common Stock (AIDX) | $3.39 Million | -59.65% | 0.38x | $9.18 Million |